35th Annual GRAL Conference
Course Goal
To promote international collaboration to further research on the diagnosis and treatment of age-related neurological disorders.
Course Learning Objectives
- To advance knowledge of brain function in normal and pathological aging
- To present strategies for health promotion and prevention of neurological disease/damage
- To demonstrate the trajectory of recovery from brain injury in aging individuals
- To characterize cognitive and functional decline in individuals with age-related neurodegenerative disease
- To promote understanding of novel therapeutic interventions for age-related neurological disease
Registration Information
| Attendee Type | price |
|---|---|
| Registration for 3 Days | $450 |
| Registration for 2 Days | $350 |
| Registration for 1 Day | $250 |
Date, Time, and Location
In Person
Thursday – Saturday, January 25-27, 2024
Barrow Neurological Institute
2910 North 3rd Avenue
Phoenix, Arizona 85013
Scroll down for campus map
Target Audience
This program is designed for physicians, neuropsychologists, psychologists, neuroscience researchers, physician assistants, and nurse practitioners.
Agenda & Speaker Information
All times refer to Arizona time.
| SPeaker | Topic & Time |
|---|---|
| Day 1 | Thursday, January 25, 2024 |
| Coffee and Breakfast | 8:00 AM |
| Yonas E. Geda, MD, MSc (Phoenix, Arizona) | Opening Ceremony (8:30 AM) |
| Danielle Eagan, PhD, ABPP (Phoenix, Arizona) | Welcome to GRAL (8:35 AM) |
| Michael Lawton, MD (Barrow CEO; Phoenix, Arizona) | Welcome To Barrow Neurological Institute (8:40 AM) |
| Bernard François Michel, MD (Marseille, France) | Brief History of GRAL (8:45 AM) |
| Bruce Price, MD (McLean Hospital, Boston, Massachusetts) | Behavioral Neurology, Neuropsychiatry, and Beyond: Where do we go from here? (9:00 AM) |
| Normal Aging | 10:00 AM |
| Gregory A. Jicha, MD, PhD (Lexington, Kentucky) | The Neurobiology of Aging (10:00 AM) |
| Nicoletta Caputi, PhD (Rome, Italy) | Physiological Cognitive Changes in Aging and How to Prevent Cognitive Decline (10:45 AM) |
| Francois Boller, MD, PhD (Washington DC, Paris France) | Q&A (11:15 AM) |
| Mild Cognitive Impairment | 11:30 PM |
| Ronald C. Petersen, MD, PhD (Rochester, Minnesota) | Mild Cognitive Impairment 2024: Diagnosis and Treatment (11:30 PM) |
| Susan Hernes, MD, PhD (Bergen, Norway) | Preliminary Results from the REACT MCI Study (12:15 PM) |
| Per Kristian Eide, MD, PhD | Glymphatic and Meningeal Lymphatic Clearance of Substances from Human Brain: Possible Implications for Neurodegenerative Disease (12:45 PM) |
| Yonas E. Geda, MD, MSc (Phoenix, Arizona) | Q&A (1:15 PM) |
| Lunch | 1:30 PM |
| Traumatic Brain Injury | 2:00 PM |
| Michael Alosco, PhD (Boston, Massachusetts) | Traumatic Encephalopathy Syndrome/CTE NIDS Criteria (2:00 PM) |
| Bernard François Michel, MD (Marseille, France) | PTSD in TBI (2:45 PM) |
| Glynnis Zieman, MD (Phoenix, Arizona) | Domestic Violence, Aging, and TBI (3:15 PM) |
| Javier Cardenas, MD (Morgantown, West Virginia) | Q&A (3:45 PM) |
| Dinner | Seasons 52 (6:00 PM) 2502 E Camelback Rd. Suite 140, 85016 |
| Day 2 | Friday, January 26, 2023 |
| Coffee and Breakfast | 8:00 AM |
| Brad A. Racette, MD (Phoenix, Arizona) | The Neurological Health Effects of Your Tesla (Grand Rounds) (8:30 AM) |
| Richard Levy, MD, PhD (Paris, France) | The Prefrontal Cortex: From Monkey to Man (9:30 AM) |
| Holly Shill, MD (Phoenix, Arizona) | Parkinson’s Disease: How Genetics is Informing Diagnosis and Treatment (10:15 AM) |
| Oury Monchi, PhD | Non-Motor Symptoms in Parkinson’s Disease: Neuroimaging and Behavioral Studies (10:45 AM) |
| Alexander Troster, PhD, ABPP-CN (Phoenix, Arizona) | Q&A (11:15 AM) |
| Lunch & Poster Session | 11:30 AM |
| Poster Session | |
| Dr. Gizachew Yismaw Wubetu | The Design and Conduct of a Plot Project on Mild Cognitive Impairment in Bahir Dar, Ethiopia |
| Ms. Mari Schibstad | Engaging the Silver Generation: Leveraging Internet and Multimedia for Recruiting Older Adults to Intervention Studies |
| Trine Holt Edwin, MD, PhD | Trajectories of Occupational Cognitive Demands and Risk of Clinically-Assessed Mild Cognitive Impairment and Dementia in Later Life |
| Geetika Chahal, MBBS Jessica Baez Cruz, B.S. Danielle Eagan, PhD, ABPP Yonas E. Geda, MD, MSc. | The Design and Conduct of a Brain Health Research Program: A Feasibility Study |
| Alzheimer’s Disease and Related Disorders | 12:00 PM |
| Anna Burke, MD (Phoenix, Arizona) | Addressing the Growing Alzheimer’s Crisis; Challenges and Opportunities (12:00 PM) |
| Justin Hoskin, MD (Phoenix, Arizona) | Cognitive Impairment in Normal Pressure Hydrocephalus (12:45 PM) |
| Parunyou Julayanont, MD (Phoenix, Arizona) | Alzheimer’s Disease and Atypical Alzheimer’s Disease Syndromes (1:15 PM) |
| George Prigatano, PhD (Phoenix, Arizona) | Love and Primary Progressive Aphasia (1:45 PM) |
| Krista Hanson, PhD, ABPP-CN (Phoenix, Arizona) | Q&A (2:15 PM) |
| Therapeutic Approaches | 2:30 PM |
| Jeffrey L Cummings, MD, ScD | Alzheimer’s Disease: The Changing Therapeutic Landscape (2:30 PM) |
| Marwan Sabbagh, MD (Phoenix, Arizona) | Applying Translational Medicine to Repurpose Cancer Drugs for Alzheimer’s Disease (3:15 PM) |
| Joseph Masdeu, MD, PhD (Houston, Texas) | Anti-Amyloid Monoclonals: Most Effective in the Pre-Symptomatic Stage (3:45 PM) |
| Bernard François Michel, MD (Marseille, France) | Q&A (4:15 PM) |
| Evening Reception | Heard Museum (6:00 PM) 2301 N Central Ave., 85004 |
| Day 3 | Saturday, January 27, 2023 |
| Coffee and Breakfast | 8:00 AM |
| Cerebrovascular & White Matter Diseases | 8:30 AM |
| Christopher Filley, MD (Aurora, Colorado) | White Matter Dementia Then and Now (8:30 AM) |
| Gustavo C. Roman, MD | The Fourth Circulation: The Importance of Glymphatic Circulation in Sleep, Dementia, and Cerebrovascular Disease (9:15 AM) |
| Anne-Marie Ergis, PhD | Multiple Sclerosis and Aging (9:45 AM) |
| Travis McCuddy, PhD (Phoenix, Arizona) | DTI Tractography and Cognitive Impairment Impairment in Vascular Dementia (10:15 AM) |
| Danielle Eagan, PhD, ABPP (Phoenix, Arizona) | Q&A and Closing Remarks (10:45 AM) |
International Scientific Committee
Bernard Francois Michel, MD
Chief Medical Officer Neurologist
Military Training Hospital Laveran Marseille, France
Yonas E. Geda, MD, MSc
Vice President, Groupe de Recherche sur la maladie d’Alzheimer (GRAL)
Professor and Program Director, Behavioral Neurology & Neuropsychiatry Fellowship Program, Barrow Neurological Institute
Francois Boller, MD, PhD
Clinical Professor of Neurology and Rehabilitation Medicine
George Washington School of Medicine & Health Sciences, Washington DC
Nicoletta Caputi, PhD
Fellow at George Washington University and University of L’Aquila, Italy
Ann-Marie Ergis, PhD
Professor at Paris Descartes, CPSC, France
Gabor G. Kovacs, MD, PhD
Professor in the Department of Laboratory Medicine & Pathobiology
University of Toronto, Canada
Bruce Price, MD
Chief, Department of Neurology, McLean Hospital, Belmont Massachusetts
Exhibitors and Sponsors
- Exhibitor and sponsor information coming soon.
Location
